SRX Global Inc. (SRXH)
SRXH moved a median of -0.70% 30 minutes after news, and -0.87% by the close. How SRXH actually reacts to news — the realized, point-in-time move the market made, measured across 151 labeled events over the last three years with zero look-ahead.
SRXH’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | -0.17% | 37% | 137 |
| 30-min | -0.70% | 40% | 142 |
| 60-min | -0.23% | 46% | 143 |
| to close | -0.87% | 41% | 141 |
| Middle 50% of SRXH reactions | -2.94% to +1.80% |
|---|---|
| Median reaction (30-min) | -0.70% |
| Measured reactions | 151 |
Half of all SRX Global Inc. news events land between -2.94% and +1.80% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
Email me when SRXH moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to SRXH's baseline. Nothing else.
Recent SRXH events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| SRX Global Commits $2.5 Million to Launch Multi-Strategy Trading Platform in Partnership with 5T Trading, Powered by the EMJX Platform | Press release | GlobeNewswire | -2.42% | -6.67% | |
| Form 8-K SRX Global Inc. For: Oct 06 | SEC filing · Form 8-K | SEC EDGAR | +4.54% | -3.25% | |
| SRX Global and CERO 1236, a Wholly-Owned SPV, Enter into Definitive Agreement to Acquire CERo Therapeutics, an Innovative Cellular Immunotherapy Company Developing CER 1236 for Hematologic Malignancies | Press release | GlobeNewswire | +2.04% | -2.54% | |
| Form 8-K SRX Global Inc. For: Oct 06 | SEC filing · Form 8-K | SEC EDGAR | +4.54% | -3.25% | |
| SRX Global Commits $1.5 Million to Launch Family of AI-Powered ETFs through its EMJX Platform, Partnering with Kupa AI Co-Founder Andy Kim | Press release | GlobeNewswire | +4.54% | -3.25% | |
| SRX Global Provides Shareholders with Update on Liquidation of Two Portfolio Investments and Adds an Investment in Onconetix (Nasdaq: ONCO) | Press release | GlobeNewswire | -0.29% | -0.86% | |
| SRX Global CEO Kent Cunningham and President of EMJX Platform Eric Jackson to Present at Webull Corporate Connect Series Fintech Investment Webinar | Press release | GlobeNewswire | +0.29% | +1.76% | |
| Form 8-K SRX Global Inc. For: Sep 08 | SEC filing · Form 8-K | SEC EDGAR | -0.65% | -2.27% | |
| SRX Global Provides Shareholder Update on Portfolio Company, ARMR Sciences, a Clinical-Stage Biodefense Company | Press release | GlobeNewswire | +0.65% | +0.65% | |
| Form 8-K SRX Global Inc. For: Aug 27 | SEC filing · Form 8-K | SEC EDGAR | +0.65% | +0.65% | |
| SRX Global Acquires Senior Secured Debt in CERo Therapeutics Holdings, Inc., an Innovative Cellular Immunotherapy Company with Cancer Fighting Molecule for the Treatment of Hematologic Cancers | Press release | GlobeNewswire | -1.76% | -1.18% | |
| Form 8-K SRX Global Inc. For: Aug 27 | SEC filing · Form 8-K | SEC EDGAR | -1.76% | -1.18% | |
| Form 8-K SRX Global Inc. For: Aug 13 | SEC filing · Form 8-K | SEC EDGAR | -1.09% | +2.75% | |
| Form 10-Q SRX Global Inc. For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | +7.31% | +12.28% | |
| SRX Global Inc. Announces Fiscal Third Quarter 2026 Financial Results | Press release | GlobeNewswire | +7.31% | +12.28% | |
| SRX Global to Host Fiscal Third Quarter 2026 Conference Call on August 13 at 4:30 p.m. ET | Press release | GlobeNewswire | -1.41% | +0.70% | |
| SRX Global Acquires Stake in Vistagen Therapeutics (NASDAQ: VTGN) | Press release | GlobeNewswire | +2.76% | -5.52% | |
| SRX Global Portfolio Company Smartkem, Inc. (NASDAQ: SMTK) Announces Merger | Press release | GlobeNewswire | +3.64% | +5.11% | |
| SRX Global Acquires Shares in Jersey Mike’s $1 Billion Initial Public Offering | Press release | GlobeNewswire | +2.18% | -9.48% | |
| Form 8-K/A SRX Global Inc. For: Jul 27 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | -2.03% | |
| Form 8-K SRX Global Inc. For: Jul 27 | SEC filing · Form 8-K | SEC EDGAR | +1.38% | +1.37% | |
| Form 8-K SRX Global Inc. For: Jul 17 | SEC filing · Form 8-K | SEC EDGAR | -2.16% | +5.91% | |
| Form 8-K SRX Global Inc. For: Jul 15 | SEC filing · Form 8-K | SEC EDGAR | -0.45% | +10.56% | |
| SRX Global Regains Full Compliance with NYSE American Listing Standards | Press release | GlobeNewswire | -3.56% | +7.11% | |
| Form 8-K SRX Global Inc. For: Jul 14 | SEC filing · Form 8-K | SEC EDGAR | +0.22% | +2.67% | |
| SRX Global Reports Paper-Traded EMJX Return of ~25% Since February 11, 2026 | Press release | GlobeNewswire | +2.29% | -11.83% | |
| Form 8-K SRX Global Inc. For: Jul 08 | SEC filing · Form 8-K | SEC EDGAR | -0.23% | +26.27% | |
| SRX Global Management Team to Host Virtual Fireside Chat on July 14, 2026, and Issues Letter to Shareholders | Press release | GlobeNewswire | +5.05% | +1.85% | |
| SRX Global Board of Directors Authorizes Stock Repurchase Plan of Up to 10 Million Shares or Up to 50% of its Shares Outstanding | Press release | GlobeNewswire | — | +40.56% | |
| SRX Global Declares One-Time Cash Dividend | Press release | GlobeNewswire | +4.47% | +66.95% | |
| SRX Global Reports Preliminary Net Asset Value of Approximately $3.07 Per Share and Over $55 Million in Cash and Short-Term Investments(1) | Press release | GlobeNewswire | — | +65.55% | |
| Form S-8 SRX Global Inc. | SEC filing · Form S-8 | SEC EDGAR | -5.23% | -21.51% | |
| SRX Global Makes Strategic Investment in Critical and Precious Minerals Development Company, Greenland Mines | Press release | GlobeNewswire | — | — | |
| Form 8-K SRX Global Inc. For: Jun 26 | SEC filing · Form 8-K | SEC EDGAR | — | — | |
| Form 8-K SRX Global Inc. For: Jun 23 | SEC filing · Form 8-K | SEC EDGAR | — | — | |
| Form DEFR14C SRX Global Inc. | SEC filing · Form DEFR14C | SEC EDGAR | — | — | |
| SRX Global Announces Share Consolidation | Press release | GlobeNewswire | — | — | |
| SRX Global Makes Strategic Investment in Clinical-Stage Biodefense Company, ARMR Sciences | Press release | GlobeNewswire | -0.14% | -14.11% | |
| Form 8-K SRx Health Solutions, For: Jun 18 | SEC filing · Form 8-K | SEC EDGAR | -3.50% | -11.07% | |
| SRx Health Solutions Closes EMJX Acquisition and Launches AI-Driven Platform Strategy Under New Name and Brand, SRX Global, Focused on Investments in High-Conviction Operating Companies and Assets | Press release | GlobeNewswire | -10.83% | -30.83% | |
| SRx Health Solutions Acquires 4.99% of Smartkem, Inc. (NASDAQ: SMTK) | Press release | GlobeNewswire | +2.02% | +1.05% | |
| SRx Health Solutions Invests in Uber Technologies, Inc. and Provides Shareholders with Portfolio Update | Press release | GlobeNewswire | -1.99% | -4.41% | |
| SRx Health Solutions and EMJX Invest in Recent IPO and Commercial-Stage Pharmaceutical Company of Psychedelics, Optimi Health Corp. (OPTH) | Press release | GlobeNewswire | -0.17% | +9.04% | |
| SRx Health Solutions Announces Board Approval to Dividend 75% of Profits from Investment in Astro Investment XVII, an Affiliate of Astro Capital and SPV with Investments in SpaceX and Other Artificial Intelligence and Space Companies | Press release | GlobeNewswire | -8.29% | -10.71% | |
| Form 10-Q SRx Health Solutions, For: Mar 31 | SEC filing · Form 10-Q | SEC EDGAR | -8.29% | -10.71% | |
| SRx Health Solutions Announces Fiscal Second Quarter 2026 Results for Quarter Ended March 31, 2026 | Press release | GlobeNewswire | -8.29% | -10.71% | |
| SRx Health Solutions Invests in Astro Investment XVII, an Affiliate of Astro Capital and SPV with Investments in SpaceX and Other Artificial Intelligence and Space Companies | Press release | GlobeNewswire | -0.17% | +24.92% | |
| Form EFFECT SRx Health Solutions, | SEC filing · Form EFFECT | SEC EDGAR | +0.00% | +0.35% | |
| Form S-4/A SRx Health Solutions, | SEC filing · Form S-4 | SEC EDGAR | -0.62% | -0.53% | |
| Form 8-K SRx Health Solutions, For: Apr 22 | SEC filing · Form 8-K | SEC EDGAR | -0.25% | -0.58% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the SRXH section they belong to.
Where else SRXH is measured.
SRXH earnings → · Analyst actions → · SEC filings →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is SRX Global Inc.'s median reaction calculated?
Every labeled SRXH news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 151 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 40% of SRXH's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does SRXH's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.